Search

everythinglearnresearchcommunity

for

Search:↓

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Sebum production varies by individual and is influenced by age, gender, and hormones, affecting skin and hair health.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

More research is needed to determine if iron deficiency causes hair loss.

Scientists have made progress in growing mini-organs and regenerating parts of the skin, with plans to treat hair loss in a future trial.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Environmental factors like temperature and nutrition affect hair growth, with humans showing seasonal hair growth differences.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Androgens and other hormones affect hair growth and skin conditions like acne.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.